干细胞之家 - 中国干细胞行业门户第一站

 

 

搜索
朗日生物

免疫细胞治疗专区

欢迎关注干细胞微信公众号

  
查看: 412634|回复: 246
go

实时定量pcr [复制链接]

Rank: 1

积分
威望
0  
包包
8  
楼主
发表于 2012-5-17 17:06 |只看该作者 |倒序浏览 |打印
Real-time quantification of microRNAs by! ?3 f2 C: Y2 Y) t' T( `9 f+ Q
stem–loop RT–PCR
# R' O& {- [# H; }6 dCaifu Chen*, Dana A. Ridzon, Adam J. Broomer, Zhaohui Zhou, Danny H. Lee,
3 r, m8 B2 E% B0 ]Julie T. Nguyen, Maura Barbisin, Nan Lan Xu, Vikram R. Mahuvakar, Mark R. Andersen,8 E8 L4 }. l- X# L7 `3 V6 P% |0 J; N
Kai Qin Lao, Kenneth J. Livak and Karl J. Guegler
# W4 l/ g# }6 Q. B" [* |Applied Biosystems, 850 Lincoln Centre Drive, Foster City, CA 94404, USA) f9 h- W3 {3 @3 C  R
Received May 24, 2005; Revised July 8, 2005; Accepted October 25, 2005" A: _6 e9 i; d  M6 l
ABSTRACT0 I5 t6 L+ o$ c* X1 `1 R0 c% X
A novel microRNA (miRNA) quantification method
) V: q8 G  ~7 V3 c6 Khas been developed using stem–loop RT followed
5 q! x- C% l8 G7 S2 B' J$ aby TaqMan PCR analysis. Stem–loop RT primers are) m, e1 n7 ~% L; x
better than conventional ones in terms of RT efficiency
) J& A/ R" C3 W8 {and specificity. TaqMan miRNA assays are specific
# r" `! W  Y* o4 V+ ?3 G3 X- Efor mature miRNAs and discriminate among+ V6 D. V+ E1 ?" C
related miRNAs that differ by as little as one nucleotide.# s1 x8 u. c- c6 H5 c) o, I
Furthermore, they are not affected by genomic
& ^7 c2 y, I7 T0 g; kDNA contamination. Precise quantification is
/ Y# a) h5 f5 {0 Nachieved routinely with as little as 25 pg of total
  X1 X1 ?; G, K3 ~! @; s9 g, n9 iRNA for most miRNAs. In fact, the high sensitivity,
* b* \3 q! z/ p/ p; V% N8 i5 fspecificity and precision of this method allows for
" L. }( p" j, q2 O' B9 P$ w4 u- A5 J: i0 x8 mdirect analysis of a single cell without nucleic acid( v  S" @5 Y5 R& }' c! n
purification. Like standard TaqMan gene expression, y( s' V% M) P
assays, TaqMan miRNA assays exhibit a dynamic
$ T% H& J% o" Y/ n) Lrange of seven orders of magnitude. Quantification
3 }  |7 @5 T7 mof five miRNAs in seven mouse tissues showed variation4 v1 U! R' H4 ?7 z- c$ U6 B/ q7 f
from less than 10 to more than 30 000 copies per" A; T% d# t( c% {  D" E& W
cell. This method enables fast, accurate and sensitive1 Z: n+ C: R8 V
miRNA expression profiling and can identify and3 ]4 ]: `  H/ }' u
monitor potential biomarkers specific to tissues or' z7 P% d0 \* x; q
diseases. Stem–loop RT–PCR can be used for the. U! v3 w7 v5 U0 ^+ k1 S9 n
quantification of other small RNA molecules such
+ o8 S. ]& [; I' ?( k9 Bas short interfering RNAs (siRNAs). Furthermore, the
- ]% T  i+ L9 l$ R: X6 mconcept of stem–loop RT primer design could be: ?5 t5 O/ t8 n
applied in small RNA cloning and multiplex assays
& i0 g5 d* H9 _( O0 f9 zfor better specificity and efficiency.
3 l! ]1 J% E% ?- wINTRODUCTION
4 Q6 l0 b9 B  x5 c. A2 g; y* C4 W$ \MicroRNAs (miRNAs) are naturally occurring, highly conserved: Z! }# X0 v8 U3 N
families of transcripts (18–25 nt in length) that are# i" P8 q: y$ V. Q7 B, T* l9 }
processed from larger hairpin precursors (1,2). miRNAs are
" N# L- r; X/ ~3 p) D- {/ wfound in the genomes of animals (3–9) and plants (10–12). To6 j7 l0 c, ?5 a
date, there are 1000 unique transcripts, including 326 human
) g9 }* P$ L, `miRNAs in the Sanger Center miRNA registry (13).+ q. V# Q4 p4 s. ^* y$ A
miRNAs regulate gene expression by catalyzing the cleavage6 r" O) W5 r0 X& {
of messenger RNA (mRNA) (14–19) or repressing mRNA
" W, D' o) K9 O6 K7 {translation (19–21). They are believed to be critical in cell
  T9 Z5 i3 [( l4 Tdevelopment, differentiation and communication (2). Specific
% a8 I% |* \( ]; @- D- Froles include the regulation of cell proliferation and metabolism. x. o, f+ Z0 {! P2 H: C- A1 X, u9 _
(22), developmental timing (23,24), cell death (25),
1 M$ Y: p* V' C+ V. Q3 _5 khaematopoiesis (26), neuron development (27), human$ B) `, n5 I6 ]4 r$ s+ [" l& V4 V
tumorigenesis (28) and DNA methylation and chromatin6 {9 L# O* }. M7 V, l( H7 F
modification (29).  k1 H& b8 \/ m6 I
Although miRNAs represent a relatively abundant class of
$ r% y  k* Z. H9 ?transcripts, their expression levels vary greatly among species
8 K5 a8 H/ p% o, ~and tissues (30). Less abundant miRNAs routinely escape
7 I" d9 i- w% y; j2 `3 R& J0 ^" ]2 m& rdetection with technologies such as cloning, northern hybridization* |' Y: b+ u1 d- y0 }
(31) and microarray analysis (32,33). Here, we present
8 d6 j- X- ^2 x' v* e3 Q, va novel real-time quantification method for accurate and sensitive
, f3 T' }5 L' h- {detection of miRNAs and other small RNAs. This method
& g) F: H! m3 |7 y9 [+ k5 ]expands the real-time PCR technology for detecting gene
: {  x- S9 }- K2 k( S! o5 P6 dexpression changes from macromolecules (e.g. mRNAs) to
' f4 o9 Y+ }6 {3 V% F- U) N  ymicro molecules (e.g. miRNAs).
) I9 U. g9 @  C( N9 |MATERIALS AND METHODS4 J4 [" [! J+ Q( X8 r* X
Targets, primers and probes (Supplementary Data)
6 ^/ {9 v) t% @9 L7 I- tSeventeen miRNA genes were selected from the Sanger2 W% c, `$ u2 G* H, e
Center miRNA Registry at http://www.sanger.ac.uk/Software/
! W, }# e; ~! cRfam/mirna/index.shtml. All TaqMan miRNA assays are
0 f& t6 ?% C  ~available through Applied Biosystems (P/N: 4365409). Standard
% F. Q$ X$ p$ I0 aTaqMan assays for pri-miRNA precursors, pri-let-7a-3% o* f1 a. j! D, d- h4 C9 F- n: n
and pri-miR-26b and pre-miRNA precursor pre-miR-30a were( r* ^1 n/ P& b- p
designed using PrimerExpress software (Applied Biosystems,  v9 p% M+ Z  l! f* q9 J
Foster City, CA). All sequences are available in the  a3 \' m- Q% D2 @& G, a
section of the Supplementary Data. Synthetic miRNA oligonucleotides
, \; h/ o9 t% z; vwere purchased from Integrated DNA Technologies3 T9 a# c# ~8 r$ u) x
Tissue RNA samples, cells, cell lysates and/ {. a5 ^. x7 r, K1 `
total RNA preparation! [) p+ R, J3 R' j7 F1 |
Mouse total RNA samples from brain, heart, liver, lung,
# g% `6 m8 u7 {2 Z7 qthymus, ovary and embryo at day 10–12 were purchased1 N7 O! P$ a8 T
from Ambion (P/N: 7810, 7812, 7814, 7816, 7818, 7824,% A: u; E1 ?! o7 N2 r
7826 and 7968). Ambion’s mouse total RNAs are derived
: l+ e# e! m; e  E% }from Swiss Webster mice. All RNA samples were normalized3 C; L+ Z) M3 L  w% G! E
based on the TaqMan Gene Expression Assays for human or# E4 F& y. k' v
mouse glyceraldehyde-3-phosphate dehydrogenase (GAPDH)
2 \' P% i* {2 ~. nendogenous controls (P/N: 4310884E and 4352339E, Applied
7 r& o9 L! E* M9 Z( f, w+ T* {Biosystems).8 j" w$ I$ ]7 x; Z# o. q. E+ e( A
Two cell lines, HepG2 and OP9, were cultured using
' G: [5 S$ j' q0 H+ g$ N/ z$ C4 R4 oGibco MEM (P/N: 12492–021, Invitrogen, Carlsbad, CA)$ x1 ^- l) v" w0 J
supplemented with 10% fetal bovine serum (FBS) (P/N:& @" e+ K/ l% o
SH30070.01, HyClone, Logan, UT). Trypsinized cells were% S' s4 g' @- ~, {
counted with a hemocytometer. Approximately 2.8 · 106
- g6 ]3 h# b$ d+ g2 d9 R4 J1 vsuspended cells were pelleted by centrifugation (Allegra 6,
( ~, ]& G, {/ u/ t* a' c; lBeckman Coulter, Fullerton, CA) at 1500 r.p.m. for 5 min,: ^0 J2 l* Q5 y
washed with 1 ml Dulbecco’s phosphate-buffered saline (PBS)
) @/ X3 K& H+ f8 X: r( ?without MgCl2 and CaCl2 (P/N: 14190078, Invitrogen, Carlsbad,
: }/ k3 u4 Q0 D+ C7 h9 {) M* PCA). The cell pellets were re-suspended in 140 ml PBS/ S: l% c4 T- z' ?
and processed with three different sample preparation methods.5 ~7 e( @9 V$ i
With the first method, a 50 ml sample (106 cells) was
+ L7 x% N0 ~4 j, hmixed with an equal amount of Nucleic Acid Purification3 {" f  J* a9 ?8 s5 j3 w
Lysis Solution (P/N: 4305895; Applied Biosystems) by pipetting7 C& k7 @9 j: X( [* ~# o( o2 j
up and down 10 times, and then spun briefly. The lysate6 |8 E4 C" W; g& r8 C
was diluted 1/10 with 1 U/ml RNase inhibitor solution (P/N:
( u% T, }2 K: ], p0 p6 WN8080119; Applied Biosystems) before adding the solution to
0 L4 k7 a% w+ W1 oan RT reaction. In the second method, a 50 ml sample (106
% M: J8 M2 [# v% n: ?+ o" l) Ccells) was used to purify total RNA using the mirVana
( {# {$ U1 K- ^4 n" a( k3 ~5 vmiRNA Isolation Kit (P/N: 1560, Ambion, Austin, TX)
& a4 t" R( h% j% F( ^+ i# caccording to the manufacturer’s protocol. Purified total
# Y2 r3 v' }+ {( p8 e, KRNA was eluted in 100 ml of elution buffer. The third method* i3 n* p3 ^& u' S0 s3 `( h
involved diluting cells 1/2 with 1· PBS, heating at 95C for 5
, C& d* f: x& r9 d2 smin, and immediately chilling on ice before aliquotting directly% P: W% I( Q0 z- X& n, O2 B
into RT reactions.
. K8 B9 z: [  ~/ u* I  J0 N9 e3 E% RmiRNA detection using mirVana miRNA$ \$ v2 b' b# |# U0 L& h9 F! P
detection kit8 J; s# z! P! y# Z7 e( G2 _. ]
Solution hybridization-based miRNA analysis was carried out
1 D; P1 ^2 y' Q0 N( _& ousing the mirVana miRNA Detection Kit (Cat. #: 1552,
  k: P8 f8 S1 O. d: D5 [" V3 z9 OAmbion) according to the manufacturer’s protocol. RNA* U; U" O6 G0 Z7 `, I0 q
probes were synthesized by IDT. The radioisotope labeled* j" Z3 l5 c1 ]
RNA fragments were detected and quantitated with a Cyclone
- R: O4 Y, o0 ~2 I" j) V& _# mStorage Phosphor System (PerkinElmer, Boston, MA).- O" |0 c  a8 F5 ?  a! F
Reverse transcriptase reactions! H) P& l" a2 I' d/ Y  @
Reverse transcriptase reactions contained RNA samples6 A1 ~- _! z. P# V) ?5 f7 [
including purified total RNA, cell lysate, or heat-treated/ P# C' b; O# A9 @
cells, 50 nM stem–loop RT primer (P/N: 4365386 and3 t: u( U) ?6 |& A" @/ G. s$ l3 u# r
4365387, Applied Biosystems), 1· RT buffer (P/N:
& e* S: v& K) h0 J4319981, Applied Biosystems), 0.25 mM each of dNTPs,
: p8 W/ @) j; e# _! K3.33 U/ml MultiScribe reverse transcriptase (P/N: 4319983,
7 x2 M4 J! t7 ~. T* b+ Q" wApplied Biosystems) and 0.25 U/ml RNase inhibitor (P/N:
' K! L4 G$ ?; o8 z$ b: Q+ k0 wN8080119; Applied Biosystems). The 7.5 ml reactions were+ D7 J" Y( t$ o0 `! Y) F% S: ?  I
incubated in an Applied Biosystems 9700 Thermocycler in a
* c% L) \3 P5 ]. F1 C5 j96- or 384-well plate for 30 min at 16C, 30 min at 42C, 5 min
( T) Y; i) }+ m; x3 q5 qat 85C and then held at 4C. All Reverse transcriptase reactions," j& `% f% c3 T0 t# ~$ R
including no-template controls and RT minus controls,2 O4 v7 c# R8 P+ y, x1 u" v# ]
were run in duplicate.- b2 ^' }6 f% O4 U
PCR" N9 x/ f' |* m/ _. d
Real-time PCR was performed using a standard TaqMan, l: p- n; j; P& O* ]
PCR kit protocol on an Applied Biosystems 7900HT Sequence
2 a4 g4 f! r- b) U; J7 hDetection System (P/N: 4329002, Applied Biosystems). The
* f9 h, a' m/ L10 ml PCR included 0.67 ml RT product, 1· TaqMan Universal" _& _. X# _" r& m
PCR Master Mix (P/N: 4324018, Applied Biosystems),4 d) S3 ]: k! D3 @" g
0.2 mM TaqMan probe, 1.5 mM forward primer and 0.7 mM
0 t/ m/ Y# U1 O9 y6 n' z0 ?% |) Areverse primer. The reactions were incubated in a 384-well  {* L7 v: H" G3 [
plate at 95C for 10 min, followed by 40 cycles of 95C for 15 s/ U) ^1 ?# `0 h) J5 u4 ^
and 60C for 1 min. All reactions were run in triplicate. The
  F3 x& d& S) U6 ?/ hthreshold cycle (CT) is defined as the fractional cycle number
" }# y1 {+ ?% `8 R' rat which the fluorescence passes the fixed threshold. TaqMan
- H! H: D& J/ y$ h/ [CT values were converted into absolute copy numbers using a
+ Y$ l# ?) v; e1 g/ lstandard curve from synthetic lin-4 miRNA.+ l: I. k0 Z$ u" F7 [
The method for real-time quantification of pri-miRNA# i, n; o( O# q7 `8 h/ v
precursors, let-7a-3 and miR-26b, and pre-miRNA precursor0 S7 T8 h& E# ?* p9 g  T
miR-30a was described elsewhere (34).
9 n, D' X: e7 N& HRESULTS6 U' z+ I% U2 u: ]+ z; i
We proposed a new real-time RT–PCR scheme for miRNA
4 p+ n9 g+ u4 d+ S' _quantification (Figure 1). It included two steps: RT and realtime, d. h. H3 L' N. I" {3 J- `
PCR. First, the stem–loop RT primer is hybridized to a! f- R* ?0 r$ [2 X
miRNA molecule and then reverse transcribed with a Multi-
! ~1 ]( Q4 V) yScribe reverse transcriptase. Next, the RT products are quantified/ w% o3 |( |# H" i/ J2 \' |
using conventional TaqMan PCR.
' ?* S0 w) C9 W9 j6 o7 W" d4 UFigure 1. Schematic description of TaqMan miRNA assays, TaqMan-based, f$ l% V7 O1 y3 p% A( E
real-time quantification of miRNAs includes two steps, stem–loop RT and realtime
2 H: o! n( }& I% }0 @# y- gPCR. Stem–loop RT primers bind to at the 30 portion of miRNA molecules9 \3 k4 w4 d  j( A
and are reverse transcribed with reverse transcriptase. Then, the RT product is1 c! S1 e  r7 z
quantified using conventional TaqMan PCR that includes miRNA-specific
' [4 {, q0 W' w8 Xforward primer, reverse primer and a dye-labeled TaqMan probes. The purpose
4 _4 L& q5 C8 h% q* B; Vof tailed forward primer at 50 is to increase its melting temperature (Tm). [, Q7 G8 `+ n
depending on the sequence composition of miRNA molecules.The dynamic range and sensitivity of the miRNA quantification
9 v$ l8 F/ h7 w: ^2 Yscheme were first evaluated using a synthetic cel-lin-4
5 I2 g: _% a$ M( X. K; X+ {) Y5 ]target. Synthetic RNA was quantified based on the A260 value
8 Q. I3 O1 _5 Iand diluted over seven orders of magnitude. The cel-lin-48 D3 E6 V6 R" [$ x( K6 O
TaqMan miRNA assay showed excellent linearity between& U8 s9 C) B" m+ B$ f- p
the log of target input and CT value, demonstrating that the
; P9 I0 F# x2 J' O! [9 lassay has a dynamic range of at least 7 logs and is capable of5 D% ]. g' k% O; \! \
detecting as few as seven copies in the PCR reaction (Figure 2).
/ g9 a/ p* e; S+ m/ [Eight additional miRNA assays were also validated using
6 R# `; p# O+ s6 lmouse lung total RNA. The RNA input ranged from 0.025 to& p7 m, v9 B8 ]# z
250 ng (Figure 3). The CT values correlated to the RNA input% {2 y5 B! r7 x" {4 L( Z8 X
(R2 > 0.994) over four orders of magnitude. A negative control
6 W; o5 j, m5 g+ [* eassay, cel-miR-2, did not give a detectable signal, even in9 Z9 e& H4 L# e
reactions with 250 ng mouse total RNA.
3 X; @) x: u; PThe expression profile of five miRNAs was determined in
" O* ~% p# {* _8 |' S: k. Jseven different mouse tissues to create a miRNA expression+ b; x' @9 @9 ~
map. The copy number per cell was calculated based on the
2 C% |5 S2 _: ]8 a# Zinput total RNA (assuming 15 pg/cell) and the standard curve
% _; B4 |$ a/ y/ ~; b6 Lof synthetic lin-4 target. Several interesting observations were# E2 O8 w/ [/ T! i  H" x
made from this expression map. First, miRNAs are very( W9 G! X: U) ?- l7 P& X
abundant, averaging 2390 copies per cell in these tissues.4 X& [3 M/ q' j# J
The level of expression ranged from less than 10 to 32 0904 n9 i1 O' p6 c9 A- ^+ Q1 L
copies per cell. Of the 12 miRNAs, miR-16 and miR-323 were
: D  I9 u5 s& h4 l& S9 ^% d+ Qthe most and least abundant miRNAs, respectively, across all
; B4 c# e8 J- Q! Y% ]* t+ ltissues. In addition, each tissue had a distinctive signature of
+ S' R% l/ r: E! v2 i8 Y9 b2 l$ TmiRNA expression. The overall level of miRNA expression
0 y; S! B( c* I0 |- D4 |was highest in mouse lung and lowest in embryos. Finally, the
0 b/ ~- L. r% r! B* T0 y' X7 odynamic range of miRNA expression varied greatly from less7 r3 M/ c, S! w/ G  _6 x7 R
than 5-fold (let-7a) to more than 2000-fold (miR-323) among
( l) P8 b* s. v( T" S+ {these seven tissues (Table 1).
% v  D8 H( n8 d3 L1 {0 WTo assess the need for RNA isolation, we added cell lysates
* R5 d. P, ^- ?; t4 g& o8 Kdirectly to miRNA assays. The equivalent of 2.5–2500 cells
/ o+ O) A7 g, r# \2 Owere added directly to 7.5 ml RT reactions. When detected,
! X8 D7 E. `6 D3 Q/ r% nthe CT values correlated (R2 > 0.998) to the number of cells inthe RT reactions over at least three orders of magnitude
# G+ i% W  ]4 r7 ](Figure 4).
( m$ i! {5 _% MThe effect of non-specific genomic DNA on TaqMan
& J" {3 J$ Z4 ?9 K8 l* BmiRNA assays was also tested for 12 assays. Results showed5 [8 x" i' ^* \3 J6 f) M
no difference in CT values in the presence or absence of 5 ng of5 C+ f% I- L. v0 |4 Y
human genomic DNA added to the RT reactions, suggesting$ b3 r4 u/ A4 Y1 G5 Y
that the assays are highly specific for RNA targets (data not$ I/ L) i! W$ a5 c
shown). Based on this observation, we added heat-treated cells
" n# E( m% n0 S9 q% ], `2 W% rdirectly to miRNA quantification assays. Figure 5 illustrates& X2 g4 c/ x& L0 j1 u0 x$ N8 q& E
the comparison of miRNA quantification using purified totalRNA, cell lysates and heat-treated cells derived from an equal  E- v0 O& V, m4 _
number of HepG2 cells. Adding heat-treated cells directly to3 N- i$ J" j' M+ |) t& m$ @' [1 J; M
the miRNA assays produced the lowest CT values, and good
% p  I) B# w+ q, m; o4 L5 Qconcordance was observed among all three different sample' H( A1 z: `0 B
preparation methods.  D# \! b2 x' b$ A0 B; D1 T
The reproducibility of TaqMan miRNA assays was
& b* i7 U, U' x# b/ p. u7 Q* Nexamined by performing12 miRNA assays with 16 replicates
* F1 v! T  U1 c9 F* qperformed by two independent operators (data not shown).) ~; e; J6 y3 [8 i
The standard deviation of the CTs averaged 0.1, demonstrating# r' X# R! E% ]7 U+ O
the high precision of the assays.0 @1 b; o$ d( |7 P/ t: `
Solution hybridization-based miRNA northern analysis was# \" `/ B. G" ?+ O
used as an independent technology to compare with TaqMan
& j+ L2 M1 Z, E3 ]" Q+ ?miRNA assays (Figure 6). We observed that hybridizationbased
  h0 f/ k7 F0 y7 t8 }' j4 {' XmiRNA analyses were less reproducible and that concordance( I1 s6 v5 M3 f9 \
with TaqMan assays varied from target to target.$ w  y9 X- S8 ~
There was a general concordance between the two methods
, `" n4 u" b2 |# o(R2 ¼ 0.916) for miR-16 across five mouse tissue samples.
9 a  R& C" q1 h: dHowever, correlations were relatively low for less abundant
' S% j! w- o5 T* T0 W3 G! x( }$ }; L; F% d6 ]miRNAs, such as miR-30 (R2 ¼ 0.751).
/ b2 P, R4 V5 uHybridization methods can lack specificity for the mature
- f( k' m% G. u0 JmiRNAs. We investigated the ability of the TaqMan miRNA
. H5 {7 @" x4 V& a: l4 C7 ]8 x6 qassays to differentiate between the mature miRNAs and their
0 B, f) X: j0 u  i2 R9 {) Vlonger precursors, using synthetic targets for pri-miRNA precursors,# C. ]* z  h# C( i  |
pri-miR-26b and pri-let-7a and pre-miRNA precursor* |% C) t" W/ L/ j% M9 \: D' A
pre-miR-30a (Table 2). TaqMan assays designed to detect
# Y/ T' d7 h& S! d3 ]- b( g5 Meither precursors or mature miRNAs were tested with synthetic
: V! _# o/ R; |6 C9 p4 A$ ntargets averaging 1.5 · 108 copies per RT reaction (1.3 · 107: H* l  s6 ]: p3 O- F* K9 K! q
copies per PCR). TaqMan miRNA analyses with only primiRNA* J1 p& K8 q) s
precursor molecules produced CT values at least( U1 \! a% d) U' }4 U; c
11 cycles higher than analyses with mature miRNA ones.
' e8 B# a9 {) \: c* Q9 W3 ~This result implies that if mature miRNA and precursor+ h# N! n( i: C; v
were at an equal concentration, the latter would contribute5 W0 V/ y( s6 N5 }1 ~+ ?
<0.05% background signal to the assay of mature target.
* x5 b5 _: g/ r' ~" K" NFor pre-miR-30a where the mature miRNA miR-30a-3p is
* r8 z) U& g6 D. C  r) Dlocated at the 30 end of the pre-miR-30a sequence, a differenceof 8.4 CT was observed. The results showed that TaqMan
' C& s# d# M- R7 w0 r* CmiRNA assays are specific to mature miRNAs. However,
; _5 o% @; I3 D  ?% ]) E8 Jthe assay specificity is better if the miRNA is located at the
8 S+ I+ x1 y  g: g9 A50 strand of the pre-miRNA precursor. Experiments analyzing0 H6 ?( t9 |7 V4 U  V
total RNA instead of synthetic targets indicated that the precursors) b: n$ S. G* R2 ?* p! f
are at least two orders of magnitude less abundant than5 ^! \1 C4 C% ]+ \/ P- e
mature miRNAs, based on CT differences of 7 or more for5 K1 ]- e% M2 z; A) J6 Z* R& }
miR-26b-1 and let-7a-2 precursors. Considered together, these
1 ?. W+ m$ e% G, U% xresults suggest that the TaqMan miRNA assays are highly4 C" C  f$ E' ~- A# _
specific for the mature miRNAs.
; \# w- y) o' v) vThe ability of the TaqMan miRNA assays to discriminate; l7 \" f& E4 H$ z0 F1 W# Y
miRNAs that differ by as little as a single nucleotide was tested
" r9 [3 L0 ]" f& |with the five synthetic miRNAs of let-7a, let-7b, let-7c, let-7d& g5 k9 E, M! @$ ?9 O# g
and let-7e (Figure 7). Each miRNA assay was examined: R2 b& i. z( |2 a# ^# G# }" }4 D- N
against each miRNA. Relative detection efficiency was calculated; _4 V) C6 f. H! e' F7 W/ q
from CT differences between perfectly matched and
9 K1 J2 P: ?2 d/ E/ P0 F3 p2 Imismatched targets, assuming 100% efficiency for the perfect
7 E& R! a" G* Wmatch. Very low levels of non-specific signal were observed,8 w- s6 `3 t* B2 s0 [
ranging from zero to 0.3% for miRNAs with 2–3 mismatched
" h, ~2 A* o  \0 n1 [bases and only 0.1–3.7% for the miRNAs that differed by a
! U/ ?3 o1 G# Usingle nucleotide. Most cross-reactions resulted from G–T
( g9 B6 x+ w$ F3 ?' s' c0 ?mismatches during the RT reaction (let-7a assay versus let-
& k% o$ o# ?4 _) h3 l" ~7c target etc.). Only the targeted miRNA was detected if more
. w, }2 i- U2 X  {than three mismatched bases between any two miRNAs were& |6 |) J! d3 _. D6 A* t
present.
6 z3 ]9 s7 r; a  U, z# CWe compared the discrimination ability of the TaqMan, h. G4 L# ~, w, d& T6 B4 p8 F/ G
miRNA assays to that of solution-based hybridization analysis
" Y3 w, E' z8 ]/ o# r' c" F(Figure 8). In our hands, the hybridization method discriminated% K7 ]: c. D5 l- m3 l3 I
well between let-7a and let-7b. However, poor or no
* m  c6 H+ t. ~1 Q0 x5 rdiscrimination was observed among let-7a, let-7c and let-! N9 Q2 D+ w' V
7d, which differ by 1–3 nt.$ F' x3 N+ @* a
We speculated that stem–loop primers might provide better
9 X1 f$ Z* T1 u+ yRT efficiency and specificity than linear ones. Base stacking of
; M6 g( w2 [. i5 M5 W% Fthe stemmight enhance the thermal stability of the RNA–DNA
6 w  Z  O: S8 Y# L3 Jheteroduplex. Furthermore, spatial constraint of the stem–loop
& e: T+ t' Y4 s3 d" h; vwould likely improve the assay specificity in comparison to4 @1 P& @, U6 z, C4 [% {
conventional linear RT primers. We compared the sensitivity
6 e; {# Y7 s( Wand specificity of the stem–loop and linear RT primers using/ u9 _1 R8 P, B4 |
synthetic miRNAs for let-7a (Figure 9). We observed several! i8 }+ ~$ \5 x3 W9 H0 K1 y
advantages for the stem–loop RT. First, in the presence of the
! e  F% X7 V; Zsynthetic let-7a target, the CT values between linear and stem–& s* z1 j9 o! [6 n' C
loop RT methods differed by 7, indicating that the efficiency of& u7 g' ?. m( s) n
stem–loop RT was at least 100 times higher. Secondly, stem–
& h. q7 ^2 O7 c' i* s& n4 hloop RT discriminated better between miRNAs that differ by; t1 h1 x" g* k5 E0 c3 V1 ~* f
two bases based on DCT values. Finally, the stem–loop RT was+ c7 x) d& E% C! p! q
at least 100 times better able to discriminate between the
: V" C7 }, l1 [6 B) y, w2 nmature miRNA and its precursor, based on the DCT (precursor: \8 {- Q$ q1 T# u! K. H9 u
versus mature) of 7.$ q) H. p9 I! f$ f) J
DISCUSSION
/ }- T, D! C1 `! A: W. P. kSince the discovery of miRNAs, remarkable advances in the
9 p$ H, ~* c: Z+ [% `2 G* ucharacterization of these gene families have delineated the6 D2 H& m2 D* l& K% @6 f" \; O2 |
mechanism for their functions in gene regulation (35). As a
. L1 p8 q* d3 Iresult, extensive surveys have begun to identify miRNA biomarkers, ?7 g: m  I0 m6 D& q# A
specific for tissue types or disease status. These studies
3 t3 g2 @, ?& ]" u! ~" ~  k& @will benefit from methods that allow for both accurate! S0 m, M5 o- S: Q4 s
identification and quantification of miRNAs.
. i  E- X2 W" E) Z% ?6 e- r* w6 FCurrent methods for detection and quantification of miRNAs
# L, ]+ ~) Q8 ^& x9 oare largely based on cloning, northern blotting (5), or' Y4 C& h4 \, ^$ I) C, v2 V6 r
primer extension (36). Although microarrays could improve' D+ x: u4 k) L1 S8 Q7 ]9 H
the throughput of miRNA profiling, the method is relatively
( A. T7 K* w& ~& Alimited in terms of sensitivity and specificity (32,33). Low
* @/ G8 W. R; k1 }& z- o$ \# Jsensitivity becomes a problem for miRNA quantification
& s9 ^2 B, K5 u$ b$ ]3 R+ Tbecause it is difficult to amplify these short RNA targets.
9 o$ g) T& R& |( K+ n0 V- e5 q. YFurthermore, low specificity may lead to false positive signalfrom closely related miRNAs, precursors and genomic$ D& t; \2 R8 K4 l
sequences. More recently, a modified Invader assay has
1 `7 f$ h) ]" M  M2 ?! ^been reported for the quantification of several miRNAs
' B9 B/ }. M. h' r7 t# U6 g(37). However, Invader assays have limited specificity and
& M, A% R) C# a2 e( ~6 ~sensitivity, requiring at least 50 ng total RNA, or 1000
" j' |. |  f: ]. Tlysed cells, per assay.
" Y% |0 u7 k( W7 P$ UReal-time PCR is the gold standard for gene expression
3 w1 N' @; {* S/ l; m9 rquantification (38,39). It has been a long challenge for scientists
! h5 v: D- b. |to design a conventional PCR assay from miRNAs averaging
! j) a5 B) ]- l8 t22 nt in length. We developed a novel scheme to
8 ]$ r, m, A& n8 H6 L! X! Xdesign TaqMan PCR assays that specifically quantify; t6 _  d) ^' L& d
miRNA expression levels with superior performance over9 O  t8 a$ k! @/ r3 f
existing conventional detection methods. We have designed
" T! B: N1 V/ ?and validated assays for 222 human miRNAs (Chen et al.,
6 Q7 F& J! G8 ]" lunpublished data). These assays combine the power of PCR! d2 E5 B. ^+ `' v. C! U8 Y+ X3 H. N
for exquisite sensitivity, real-time monitoring for a large6 r; F* w  @+ [
dynamic range and TaqMan assay reporters to increase the
8 b; @& V* c9 D) E0 w& R) D) Ospecificity. In our hands, miRNA precursors were at least 2000/ K: X4 }- G' k4 ~' G
times less effective targets than mature miRNAs (Table 2)." T% V: |+ s) k
Because these assays are insensitive to precursors or genomic# c+ r3 o( x3 F8 {2 N2 Q
DNA, we were able to add heat-treated cells directly to the/ h' c' [8 o. Y% N" I( {# v
assays, eliminating the need for sample preparation. For1 I" G! p( R, K8 l
applications where both mature miRNAs and their precursors
; c, g6 w3 W3 y/ f# C2 n  xneed to be assayed, conventional TaqMan assays can be used
9 h1 v( X! ~/ r2 win parallel to specifically detected precursors.! M9 A- R* A" u' P2 U5 F
We observed the better specificity and sensitivity of stem–
! a, F: |& \4 V6 M5 P1 U7 m  q  hloop RT primers than conventional linear ones likely due to the
5 [7 X: q( O$ X3 B) z6 U0 K/ [base stacking and spatial constraint of the stem–loop structure) C* y$ D6 [! {& _  \) q* n5 h; S
(Figure 9). The base stacking could improve the thermal stability% k$ _' ^* j; a8 t. N* o1 \9 t
and extend the effective footprint of RT primer/RNA8 \+ U: U& |' X2 Z
duplex that may be required for effective RT from relatively: |  ]- I1 T  a( x& C
shorter RT primers. The spatial constraint of the stem–loop
% [5 v. K. O  @( W. L* _structure may prevent it from binding double-strand genomic
5 S& _6 n+ X" G+ }3 G2 A9 ADNA molecules and, therefore, eliminate the need of TaqMan. n) c( j0 |9 l2 ?; }+ u
miRNA assays for RNA sample preparation. Stem–loop
+ ]) b4 H. M( k; e' F, t+ H9 DRT primers can potentially be used for multiplex RT reactions
% D8 g, K) h1 n( iand small RNA cloning for possibly better efficiency and4 }- Z9 A) {% c  U. e
specificity.& A3 h/ Q  e, @9 c
There is an increasing need for sensitive and specific whole
) e; G% i  d- l- i9 @miRNA profiling. The ability to effectively profile miRNAs
, y% ]  E& B: V. G) Ccould lead to the discoveries of disease- or tissue-specific" x7 u. v! X; \* x
miRNA biomarkers, as well as contribute to the understanding0 j! `; [7 M. Y* Q7 O; ~& C
of how miRNAs regulate stem cell differentiation. Our stem–
9 _8 K# i9 {! ]/ n4 U$ xloop RT–PCR method should provide a practical solution for
) _( ~9 ~! `0 K- `/ fthese studies. We are currently developing multiplex) B, t  M: P: ?$ c9 e3 g
approaches that should further increase the utility of this: t+ @2 z/ T, B2 J+ X
method.

Rank: 2

积分
61 
威望
61  
包包
1757  
沙发
发表于 2015-5-26 21:10 |只看该作者
这个贴不错!!!!!  

Rank: 2

积分
116 
威望
116  
包包
1832  
藤椅
发表于 2015-6-4 17:10 |只看该作者
挺好啊  

Rank: 2

积分
122 
威望
122  
包包
1876  
板凳
发表于 2015-7-18 15:44 |只看该作者
干细胞之家微信公众号
一楼的位置好啊..  

Rank: 2

积分
104 
威望
104  
包包
1772  
报纸
发表于 2015-7-21 08:27 |只看该作者
支持你一下下。。  

Rank: 2

积分
61 
威望
61  
包包
1757  
地板
发表于 2015-8-8 19:24 |只看该作者
其实回帖算是一种没德德,所以我快成圣人了  

Rank: 2

积分
64 
威望
64  
包包
1782  
7
发表于 2015-8-29 13:42 |只看该作者
怎么就没人拜我为偶像那?? ~  

Rank: 2

积分
162 
威望
162  
包包
1746  
8
发表于 2015-8-29 16:01 |只看该作者
快毕业了 希望有个好工作 干细胞还是不错的方向

Rank: 2

积分
79 
威望
79  
包包
1769  
9
发表于 2015-9-12 19:01 |只看该作者
我喜欢这个贴子  

Rank: 2

积分
107 
威望
107  
包包
1889  
10
发表于 2015-9-28 20:55 |只看该作者
观看中  
‹ 上一主题|下一主题
你需要登录后才可以回帖 登录 | 注册
验证问答 换一个

Archiver|干细胞之家 ( 吉ICP备2021004615号-3 )

GMT+8, 2024-6-9 09:33

Powered by Discuz! X1.5

© 2001-2010 Comsenz Inc.